相似文献
1
CaIPF14030 negatively modulates intracellular ATP levels during the development of azole resistance in Candida albicans.
Acta Pharmacol Sin. 2011 Apr;32(4):512-8. doi: 10.1038/aps.2010.232.
2
Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters.
Antimicrob Agents Chemother. 1995 Nov;39(11):2378-86. doi: 10.1128/AAC.39.11.2378.
3
RTA2, a novel gene involved in azole resistance in Candida albicans.
Biochem Biophys Res Commun. 2008 Sep 5;373(4):631-6. doi: 10.1016/j.bbrc.2008.06.093. Epub 2008 Jul 2.
4
RTA2 is involved in calcineurin-mediated azole resistance and sphingoid long-chain base release in Candida albicans.
Cell Mol Life Sci. 2009 Jan;66(1):122-34. doi: 10.1007/s00018-008-8409-3.
5
[Azole resistance in Candida albicans].
Rev Esp Quimioter. 2000 Sep;13(3):314-7.
6
Antagonism of azole activity against Candida albicans following induction of multidrug resistance genes by selected antimicrobial agents.
Antimicrob Agents Chemother. 1999 Aug;43(8):1968-74. doi: 10.1128/AAC.43.8.1968.
7
Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients.
Antimicrob Agents Chemother. 2001 Oct;45(10):2676-84. doi: 10.1128/AAC.45.10.2676-2684.2001.
8
The Rpd3/Hda1 family of histone deacetylases regulates azole resistance in Candida albicans.
J Antimicrob Chemother. 2015 Jul;70(7):1993-2003. doi: 10.1093/jac/dkv070. Epub 2015 Mar 29.
9
New evidence that Candida albicans possesses additional ATP-binding cassette MDR-like genes: implications for antifungal azole resistance.
J Med Vet Mycol. 1997 Mar-Apr;35(2):133-7.
10
Loss of C-5 Sterol Desaturase Activity in : Azole Resistance or Merely Trailing Growth?
Antimicrob Agents Chemother. 2018 Dec 21;63(1). doi: 10.1128/AAC.01337-18. Print 2019 Jan.
引用本文的文献
1
RNase III coding genes modulate the cross-kingdom biofilm of and .
Front Microbiol. 2022 Sep 30;13:957879. doi: 10.3389/fmicb.2022.957879. eCollection 2022.
本文引用的文献
1
Proteomic analysis reveals a synergistic mechanism of fluconazole and berberine against fluconazole-resistant Candida albicans: endogenous ROS augmentation.
J Proteome Res. 2009 Nov;8(11):5296-304. doi: 10.1021/pr9005074.
2
RTA2, a novel gene involved in azole resistance in Candida albicans.
Biochem Biophys Res Commun. 2008 Sep 5;373(4):631-6. doi: 10.1016/j.bbrc.2008.06.093. Epub 2008 Jul 2.
3
Candida albicans drug resistance another way to cope with stress.
Microbiology (Reading). 2007 Oct;153(Pt 10):3211-3217. doi: 10.1099/mic.0.2007/010405-0.
4
Harnessing calcineurin as a novel anti-infective agent against invasive fungal infections.
Nat Rev Microbiol. 2007 Jun;5(6):418-30. doi: 10.1038/nrmicro1680.
5
Identification and characterization of a functional Candida albicans homolog of the Saccharomyces cerevisiae TCO89 gene.
FEMS Yeast Res. 2007 Jun;7(4):558-68. doi: 10.1111/j.1567-1364.2007.00210.x. Epub 2007 Feb 9.
6
cDNA microarray analysis of differential gene expression and regulation in clinically drug-resistant isolates of Candida albicans from bone marrow transplanted patients.
Int J Med Microbiol. 2006 Oct;296(6):421-34. doi: 10.1016/j.ijmm.2006.03.004. Epub 2006 Jun 19.
7
CRZ1, a target of the calcineurin pathway in Candida albicans.
Mol Microbiol. 2006 Mar;59(5):1429-51. doi: 10.1111/j.1365-2958.2005.05037.x.
8
Changing patterns and trends in systemic fungal infections.
J Antimicrob Chemother. 2005 Sep;56 Suppl 1:i5-i11. doi: 10.1093/jac/dki218.
9
An update on antifungal targets and mechanisms of resistance in Candida albicans.
Med Mycol. 2005 Jun;43(4):285-318. doi: 10.1080/13693780500138971.
10
Multidrug resistance in yeast Candida.
Int Rev Cytol. 2005;242:215-48. doi: 10.1016/S0074-7696(04)42005-1.
Zotero 插件